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Abstract The coordination chemistry of the 2-His-1-car-
boxylate facial triad mimics 3,3-bis(1-methylimidazol-2-yl)
propionate (MIm2Pr) and 3,3-bis(1-ethyl-4-isopropylimi-
dazol-2-yl) propionate (iPrEtIm2Pr) towards ZnCl2 was
studied both in solution and in the solid state. Different
coordination modes were found depending both on the
stoichiometryandontheligandthatwasemployed.Inthe2:1
ligand-to-metal complex [Zn(MIm2Pr)2], the ligand coor-
dinates in a tridentate, tripodal N,N,O fashion similar to the
2-His-1-carboxylate facial triad. However, the 1:1 ligand-
to-metal complexes [Zn(MIm2Pr)Cl(H2O)] and [Zn(iPrE-
tIm2Pr)Cl] were crystallographically characterized and
found to be polymeric in nature. A new, bridging coordina-
tion mode of the ligands was observed in both structures
comprising N,N-bidentate coordination of the ligand to one
zinc atom and O-monodentate coordination to a zinc second
atom. A rather unique transformation of pyruvate into oxa-
late was found with [Zn(MIm2Pr)Cl], which resulted in the
isolation of the new, oxalato bridged zinc coordination
polymer [Zn2(MIm2Pr)2(ox)] 6H2O, the structure of which
was established by X-ray crystal structure determination.
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Introduction
The 2-His-1-carboxylate facial triad is a structural motif of
increasing prominence among structurally characterized
metalloenzymes. Next to the rapidly growing subgroup of
non-heme iron enzymes [1, 2], several mononuclear zinc
enzymes also feature this triad at their active site [3]. The
proteases thermolysin, carboxypeptidase, and neutral pro-
tease, for example, catalyze the hydrolysis of peptide bonds.
The zinc ion in these enzymes is coordinated by three
endogenous residues, i.e., one glutamate and two histidine
residues (Fig. 1). The fourth coordination site of the
pseudo-tetrahedral zinc center is occupied by a catalytically
important water or hydroxide ligand. This 2-His-1-carbox-
ylate facial triad is a variation of the most commonly
observed structural motif for the active sites of zinc-
containing enzymes. Typically, the tetrahedral zinc centers
in these enzymes are bound by a combination of histidine
(N), glutamate or aspartate (O) and/or cysteine (S) residues.
The resulting NxOySz donor set determines its biological
function [3]. Accordingly, it is important to understand how
a particular combination of donor groups modulates the
reactivity of the Zn(II) metal center.
The study of small synthetic analogues has focused on
establishing a basis for such a structure–function relation-
ship for these mononuclear zinc-containing enzymes [3, 5].
Initially, pioneering studies by the groups of Vahrenkamp,
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such as the trispyrazolylborates [6–8]. In order to obtain
close structural models for the 2-His-1-carboxylate facial
triad containing zinc enzymes, one would preferentially
like to construct small analogues based on a tripodal N,N,O
ligand framework that incorporates the biologically rele-
vant donor groups. Of the complexes with a mixed N/O
donor set reported to date [9–22], only a few make use of
such tridentate, tripodal N,N,Ocarboxylato ligands. These
tripodal ligands should be particularly well suited for the
structural modeling of tetrahedral metal centers [23].
Dowling and Parkin [24] and Ghosh and Parkin [25]
reported the ﬁrst example of an N,N,O model complex with
a carboxylato donor group, which resulted from the inser-
tion of carbon dioxide into a borohydride bond. More
recently, the groups of Burzlaff [9, 12] and Carrano [11,
18, 19] have reported studies on the zinc coordination
chemistry of the bispyrazolylacetate ligand family. Beck
et al. [9], for instance, reported that a 2:1 ligand–zinc
complex was obtained with bis(3,5-dimethylpyrazol-2-
yl)acetate (bdmpza), a ligand closely related to 3,3-bis(1-
methylimidazol-2-yl)propionate (MIm2Pr). These 2:1
complexes were obtained regardless of the ratio of reac-
tants, i.e., even with stoichiometric amounts of ligand and
zinc(II). Very recently, Friese et al. [22] constructed
mononuclear zinc models via a new approach, i.e., by the
use of sterically hindered carboxylato and N-donor ligand
building blocks.
We have been studying the copper and iron coordination
chemistry of the new ligand family of the substituted 3,3-
bis(1-alkylimidazol-2-yl)propionates as accurate structural
mimics of the 2-His-1-carboxylate facial triad [26–28].
These ligands incorporate the biologically relevant donor
groups, i.e., two imidazoles and a carboxylate group, into a
monoanionic, tripodal framework. Their general biomi-
metic potential has been illustrated by the structurally
characterized copper [27, 28] and iron [26] complexes of
these ligands. Here, our studies are expanded to the
structural modeling of the zinc-containing enzymes and
describe the zinc coordination chemistry of the ligands
MIm2Pr and 3,3-bis(1-ethyl-4-isopropylimidazol-2-yl)pro-
pionate (iPrEtIm2Pr) (Fig. 2). Furthermore, the attempted
synthesis of zinc complexes with 3,3-bis(1-methylimi-
dazol-2-yl)acetate (MIm2Ac), a direct analogue of the
bispyrazolylacetates, is described. During the course of
these studies, we found that zinc complexes of ligand
MIm2Pr catalyze the unexpected and unprecedented con-
version of pyruvate to oxalate in aqueous solution.
Materials and methods
Air-sensitive organic reactions were carried out under an
atmosphere of dry, oxygen-free N2 using standard Schlenk
techniques. Tetrahydrofuran (THF) and diethyl ether were
dried over sodium benzophenone ketyl and distilled under
N2 prior to use. Methanol was dried over magnesium
methoxide and distilled under N2 prior to use.
1H and
13C
NMR spectra were recorded using a Varian AS400, a
Varian Inova 300, or a Varian Mercury 200 spectrometer,
operating at 25  C. IR spectra were recorded with a Perk-
inElmer Spectrum One Fourier transform IR instrument.
Elemental microanalyses were carried out by the Micro-
analytisches Laboratorium Dornis & Kolbe, Mulheim a.d.
Ruhr, Germany. ESI–MS spectra were recorded using a
Fig. 1 Active site of a zinc-containing enzyme that features the 2-
His-1-carboxylate facial triad: neutral protease from Bacillus cereus
(Protein Data Bank accession code 1NPC.pdb) [4]
Fig. 2 Ligands 3,3-bis
(1-methylimidazol-2-yl)
propionate (MIm2Pr),
3,3-bis(1-ethyl-4-
isopropylimidazol-2-yl)
propionate (iPrEtIm2Pr), and
3,3-bis(1-methylimidazol-2-yl)
acetate (MIm2Ac) and the
synthesis of the zinc complexes
[Zn(MIm2Pr)2],
[Zn(MIm2Pr)Cl], and
[Zn(iPrEtIm2Pr)Cl]
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ectrometer at the Biomolecular Mass Spectrometry Group,
Utrecht University. Bis(1-methylimidazol-2-yl)methane
(MIm2CH2)[ 29,] 3,3-bis(1-methylimidazol-2-yl)propionic
acid (HMIm2Pr), potassium and tetrabutylammonium
3,3-bis(1-methylimidazol-2-yl)propionate (K[MIm2Pr] and
[Bu4N][MIm2Pr]) [27], potassium 3,3-bis(1-ethyl-4-iso-
propylimidazol-2-yl)propionate (K[iPrEtIm2Pr]) [26], and
zinc bis(trimethylsilyl)amide [30] were prepared according
to published procedures. All other chemicals were obtained
commercially and used as received.
Benzyl bis(1-methylimidazol-2-yl)acetate
To a cooled solution of MIm2CH2 (0.52 g, 3.0 mmol) in dry
THF (50 mL) at –78  C was added dropwise a solution of
n-butyl lithium in hexane (2.0 mL, 3.2 mmol). The reaction
mixture was stirred for 1 h at –78  C, after which benzyl-
chloroformate (1.19 mL, 3.5 mmol, 50 wt% solution in
toluene) was added dropwise. During the addition, a white
precipitate formed. The solution was allowed to warm to
room temperature overnight. The reaction mixture was
quenched with H2O (20 mL) and all volatiles were removed
in vacuo. The aqueous layer was extracted with diethyl
ether (4 · 20 mL) and the combined organic layers were
dried over MgSO4, ﬁltered and concentrated in vacuo. The
crude oil was puriﬁed by column chromatography (SiO2,
ethyl acetate–methanol 2:1). Benzyl bis(1-methylimidazol-
2-yl)acetate (BnMIm2Ac) was isolated as a yellow oil in
62% yield (0.58 g, 1.9 mmol).
1H NMR (300 MHz,
CD3CN, 25  C): d = 3.44 (s, 6H, NCH3), 5.23 (s, 2H, CH2),
5.62 (s, 1H, CH), 6.85 (s, 2H, Him), 6.96 (s, 2H, Him), 7.35
(s, 5H, HPh) ppm. Anal. for C17H18N4O2 (310.35): calc. C
65.79, H 5.85, N 18.05; found C 65.88, H 5.74, N 17.92. IR
(solid): m = 3,122.9, 2,911.5, 1,734.5, 1,547.4, 1,510.2,
1,454.4, 1,373.6, 1,263.4, 1,220.8, 1,150.4, 978.2, 958.3,
907.1, 847.8, 785.7, 776.5, 740.1, 696.7, 683.5, 665.3 cm
–1.
ESI–MS: m/z = 409.0 ([M–Cl]
+, calc. 409.0).
[Zn(MIm2Pr)2]
To a hot, colorless solution of HMIm2Pr (282 mg,
1.20 mmol) in dry acetonitrile (100 mL) was added a
solution of Zn[N(SiMe3)2]2 (232 mg, 0.60 mmol) in dry
diethyl ether (20 mL) via a cannula. The resulting color-
less, clear solution was stirred for 60 h at elevated
temperature, during which gradually a white precipitate
formed. The reaction mixture was concentrated in vacuo to
give the crude product as a white powder. Recrystallization
from an acetone–water mixture (4:1 v/v) gave [Zn
(MIm2Pr)2] as a colorless crystalline solid (230 mg, 72%).
1H NMR (300 MHz, D2O, 25  C): d = 2.69 (d, 2H,
J = 6.3 Hz, CHCH2), 3.74 (s, 6H, NCH3), 4.93 (t, 1H,
J = 6.0 Hz, CHCH2), 6.69 (s, 2H, Him), 7.00 (s, 2H, Him)
ppm.
13C{
1H} NMR (50 MHz, D2O, 25  C): d = 30.2,
33.4, 43.6, 122.7, 125.7, 146.8, 177.2 ppm. Anal. for
C22H26ZnN8O4 (531.90): calc. C 49.68, H 4.93, N 21.07;
found C 49.76, H 5.06, N 20.97. IR (solid): m = 3,120.2,
2,951.7, 2,907.1, 2,815.2, 1,580.5, 1,508.1, 1,427.1,
1,391.0, 1,306.4, 1,288.0, 1,229.3, 1,168.8, 1,143.3,
1,044.8, 956.9, 906.2, 769.3, 751.1 cm
–1. ESI–MS: m/z =
531.18 ([M + H]
+, calc. 531.14), 553.18 ([M+Na]
+, calc.
553.13), 569.16 ([M + K]
+, calc. 569.10).
[Zn(MIm2Pr)Cl]
To a hot, colorless solution of K[MIm2Pr] (255 mg,
0.93 mmol) in dry methanol (5 mL) was added a solution
of ZnCl2 (127 mg, 0.93 mmol) in methanol (5 mL) via a
cannula. Immediately upon addition a white precipitate
formed and the suspension was stirred at elevated tem-
perature for 1 h. The white precipitate was separated by
centrifugation and washed with methanol (3 · 20 mL).
[Zn(MIm2Pr)Cl] was obtained as a white powder in almost
quantitative yield (305 mg, 98%).
1H NMR (300 MHz,
D2O, 25  C): d = 2.80 (d, 3H, J = 3.3 Hz, CHCH2), 3.85
(s, 6H, NCH3), 4.99 (t, 1H, CH2CH), 6.99 (s, 2H, Him),
7.14 (s, 2H, Him) ppm.
13C{
1H} NMR (50 MHz, D2O,
25  C): d = 29.8, 33.4, 42.6, 122.5, 125.5, 146.1,
177.3 ppm. Anal. for C11H13ClN4O2Zn (334.11): calc. C
39.55, H 3.92, N 16.77; found: C 39.46, H 4.05, N 16.85.
IR (solid): m = 3,138.0, 3,117.2, 1,614.8, 1,508.2, 1389.8,
1,299.8, 1,289.5, 1,151.7, 1,142.5, 1,089.7, 976.2, 949.7,
796.3, 765.3, 736.1 cm
–1. ESI–MS: m/z = 296.94 ([M–
Cl]
+, calc. 297.03), 332.92 ([M + H]
+, calc. 333.01),
413.97 ([3M–Zn–3Cl + H]
2+, calc. 414.09), 531.02 ([2M–
Zn–2Cl + H]
+, calc. 531.15), 628.97 ([2M–Cl]
+, calc.
629.03), 827.10 ([3M–Zn–3Cl]
+, calc. 827.17).
[Zn(MIm2Pr)Cl(H2O)]
Colorless crystals of [Zn(MIm2Pr)Cl(H2O)] suitable for
X-ray diffraction were obtained upon standing of a con-
centrated solution of [Zn(MIm2Pr)Cl] in H2O for several
weeks. The coordination polymer obtained is insoluble in
all common organic solvents and water of neutral pH. Anal.
for C11H15ClN4O3Zn (352.12): calc. C 37.52, H 4.29,
15.91; found C 37.44, H 4.27, N 15.97. IR (solid):
m = 3,408.6, 3,113.5, 3,134.7, 1,594.5, 1,504.5, 1,403.1,
1,306.7, 1,255.5, 1,155.5, 1,136.3, 1,087.4, 983.7, 959.1,
934.9, 849.7, 764.6, 743.1, 717.6 cm
–1.
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To a colorless solution of ZnCl2 (30 mg, 0.22 mmol) in dry
methanol (10 mL) was added a solution of K[iPrEtIm2Pr]
(85 mg, 0.22 mmol) in dry methanol (15 mL) via a can-
nula. The clear solution was stirred overnight at room
temperature and evaporated in vacuo. The product was
redissolved in dichloromethane and insoluble KCl was
separated off by centrifugation. The solution was ﬁltered
over Celite and concentrated in vacuo to give [Zn(iPrE-
tIm2Pr)Cl] as a white powder (97 mg, 99%). Colorless
crystals suitable for X-ray diffraction were obtained from a
methanolic solution of [Zn(iPrEtIm2Pr)Cl] upon standing.
1H NMR (300 MHz, D2O, 25  C): d = 1.22 (d, 6H,
J = 7.2 Hz, CH3CHCH3), 1.25 (d, 6H, J = 6.8 Hz,
CH3CHCH3), 1.44 (t, 6H, J = 7.2 Hz, CH3CH2), 2.88 (d,
2H, J = 6.0 Hz, CHCH2), 3.25 (m, 2H, CH3CHCH3), 4.21
(ABX3, 2H, J = 7.2, CHHCH3), 4.32 (ABX3, 2H, J = 7.2,
CHHCH3), 5.02 (t, 1H, J = 5.7 Hz, CHCH2), 6.99 (s, 2H,
Him) ppm.
13C{
1H} NMR (100 MHz, CD3OD, 25  C):
d = 16.6, 22.1, 24.1, 28.0, 31.1, 42.9, 116.0, 146.2, 149.9,
175.7 ppm. Anal. for C19H29ClN4O2Zn (446.32): calc. C
51.13, H 6.55, N 12.55; found: C 51.05, H 6.43, N 12.37.
IR (solid): m = 3,101.4, 2,967.9, 2,873.7, 1,626.6, 1,572.8,
1,494.8, 1,448.9, 1,464.1, 1,381.1, 1,324.8, 1,257.2,
1,175.8, 1,153.0, 1,027.6, 976.1, 801.2, 757.7, 660.5 cm
–1.
ESI–MS: m/z = 409.13 ([2M–2Cl]
2+, calc. 409.16), 445.11
([M + H]
+, calc. 445.13), 483.04 ([M + K]
+, calc. 483.09),
631.21 ([3M–2Cl]
2+, calc. 631.22), 853.29 ([2M–Cl]
+,
calc. 853.29), 889.20 ([2M + H]
+, calc. 889.26), 1297.02
([3M + H]
+, calc. 1297.42).
[Zn(BnMIm2Ac)Cl2]
To a hot solution of BnMIm2Ac (259 mg, 0.84 mmol) in
dry methanol (5 mL) was added a solution of anhydrous
ZnCl2 (115 mg, 0.84 mmol) in dry MeOH (5 mL) via a
cannula. The reaction mixture was stirred at elevated
temperature for 1 h and gradually the product formed as a
white precipitate. The product [Zn(BnMIm2Ac)Cl2] was
separated by centrifugation and was obtained as a white
powder in quantitative yield. Single crystals suitable for X-
ray analysis were obtained by slow evaporation of a solu-
tion of [Zn(BnMIm2Ac)Cl2] in acetone.
1HN M R
(300 MHz, CD3CN, 25  C): d = 3.79 (2, 6H, CH3), 5.12 (s,
2H, CH2), 5.60 (s, 1H, CH), 7.13 (d, 2H, J = 0.75 Hz,
Him), 7.22 (d, 2H, J = 0.75 Hz, Him), 7.25 (m, 2H, HPh),
7.33 (m, 3H, HPh) ppm.
13C{
1H} NMR (100 MHz,
CD3OD, 25  C): d = 34.9, 40.6, 69.7, 124.5, 126.5, 129.1,
129.5, 129.7, 136.1, 142.3, 166.2 ppm. Anal. for
C17H18Cl2N4O2Zn (446.67): calc. C 45.71, H 4.06, N
12.54; found C 45.64, H 3.95, N 12.61. IR (solid):
m = 3,122.9, 2,911.5, 1,734.5, 1,547.4, 1,510.2, 1,454.4,
1,373.6, 1,263.4, 1,220.8, 1,150.4, 978.2, 958.3, 907.1,
847.8, 785.7, 776.5, 740.1, 696.7, 683.5, 665.3 cm
–1.
ESI–MS: m/z = 409.0 ([M–Cl]
+, calc. 409.0).
[Zn2(MIm2Pr)2(ox)] (direct synthesis)
To a solution of [Zn(MIm2Pr)Cl] (50 mg, 0.15 mmol) in
water (5 mL) was added a solution of potassium oxalate
hydrate (14 mg, 0.075 mmol) in water (3 mL). The solu-
tion was stirred overnight at room temperature, during
which gradually a white precipitate formed. The precipitate
was separated by centrifugation and washed three times
with water (3 · 20 mL). The product [Zn2(MIm2Pr)2(ox)]
was dried in vacuo and obtained as a white powder in 82%
yield (42 mg, 0.061 mmol). Anal. for C24H26N8O8
Zn2 6H2O (685.33): calc. C 36.33, H 4.83, N 14.12; found:
C 36.45, H 4.50, N 14.25. IR (solid): m = 3,476.8, 3,135.4,
1,671.3, 1,651.6, 1,600.2, 1,544.9, 1,504.8, 1,423.6,
1,382.7, 1,320.1, 1,287.2, 1,158.1, 1,137.9, 985.1, 769.4,
745.1, 710.4 cm
–1.
[Zn2(MIm2Pr)2(ox)] 6H2O, reaction of [Zn(MIm2Pr)Cl]
with sodium pyruvate
For NMR investigation of reaction mixtures, stock solu-
tions of [Zn(-MIm2Pr)Cl] (20 mg, 0.06 mmol) in H2O
(1 mL) and sodium pyruvate (13.2 mg, 0.06 mmol) in H2O
(2 mL) were prepared. NMR tubes were ﬁlled with 0.1 mL
of each stock solution and kept either at room temperature
or heated to 50  C. The NMR samples were analyzed at
different times after mixing the reagents. Before acquisi-
tion of the NMR spectrum, 0.4 mL D2O was added to the
reaction mixture. Crystals usually deposited within 2 or
3 days in the NMR tube.
In the case of the catalytic runs, 0.1 mL of a solution
containing 20 equiv of sodium pyruvate was added to
0.1 mL of the [Zn(MIm2Pr)Cl] stock solution and dimethyl
sulfoxide (5 equiv, 11 lL) was added as an internal stan-
dard. The reaction mixture was kept at 50  C and the NMR
spectrum was recorded with addition of 0.4 mL D2O after
24 h.
On a preparative scale, to a solution of ZnCl2 (37 mg,
0.27 mmol) and K[MIm2Pr] (75 mg, 0.27 mmol) in H2O
(10 mL) was added sodium pyruvate (30 mg, 0.27 mmol).
The solution was heated to 50  C and gradually an off-
white precipitate was formed. After 1 week, the product
was separated by centrifugation (29 mg, 31%). The IR
spectrum of the product was identical to that of indepen-
dently synthesized [Zn2(MIm2Pr)2(ox)].
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[Zn(MIm2Pr)Cl(H2O)], [Zn(iPrEtIm2Pr)Cl],
ZnCl2(BnMIm2Ac)], [ZnCl2(MIm2CH2)],
and [Zn2(MIm2Pr)2(ox)] 6H2O
Reﬂections were measured with a Nonius Kappa CCD
diffractometer with a rotating anode (graphite monochro-
mator, k = 0.71073 A ˚) at –123  C. The structures were
reﬁned with SHELXL-97 [31] against F
2 of all reﬂections.
Non-hydrogen atoms were reﬁned with anisotropic dis-
placement parameters. Geometry calculations and checking
for higher symmetry were performed with the PLATON
program [32]. Further details are given in Table 1.
For Zn(MIm2Pr)Cl(H2O)] the structure was solved with
SHELXS-97 [33] using direct methods. All hydrogen
atoms were located in the difference Fourier map and
reﬁned freely with isotropic displacement parameters.
For [Zn(iPrEtIm2Pr)Cl] the structure was solved with
DIRDIF-99 [34] using automated Patterson methods.
Reﬁnement was performed as an inversion twin. All
hydrogen atoms were located in the difference Fourier map
and reﬁned with a riding model.
For ZnCl2(BnMIm2Ac)] the structure was solved with
DIRDIF-99 [34] using automated Patterson methods. All
hydrogen atoms were located in the difference Fourier map
and reﬁned with a riding model.
For [ZnCl2(MIm2CH2)] the structure was solved with
SIR-97 [35] using Direct methods. All hydrogen atoms
were located in the difference Fourier map and reﬁned
freely with isotropic displacement parameters.
For [Zn2(MIm2Pr)2(ox)] 6H2O the crystal was nonme-
rohedrally twinned with a twofold rotation about the
crystallographic c-axis as a twin operation. This twin law
was taken into account during the intensity integration
Table 1 Crystallographic data for compounds [Zn(MIm2Pr)Cl(H2O)], [Zn(iPrEtIm2Pr)Cl], ZnCl2(BnMIm2Ac)], [ZnCl2(MIm2CH2)], and
[Zn2(MIm2Pr)2(ox)] 6H2O
Compound [Zn(MIm2Pr)Cl(H2O)] [Zn(iPrEtIm2Pr)Cl] [ZnCl2(BnMIm2Ac)] [ZnCl2(MIm2CH2)] [Zn2(MIm2Pr)2(ox)] 6H2O
Formula C11H15ClN4O3Zn C19H29ClN4O2Zn C17H18Cl2N4O2Zn C9H12Cl2N4Zn C24H26N8O8Zn2 6H2O
FW 352.09 446.28 446.62 312.50 793.36
Crystal size (mm
3) 0.30 · 0.12 · 0.09 0.18 · 0.03 · 0.03 0.60 · 0.03 · 0.03 0.30 · 0.15 · 0.06 0.24 · 0.18 · 0.09
Crystal color Colorless Colorless Colorless Colorless Colorless
Crystal system Orthorhombic Monoclinic Monoclinic Monoclinic Triclinic
Space group P212121 (no. 19) Cc (no. 9) C2/c (no. 15) P21/c (no. 14) P 1 ðno. 2Þ
a (A ˚) 8.7159(1) 10.1766(2) 35.5761(4) 7.3547(1) 9.9634(7)
b (A ˚) 10.1124(1) 23.8561(6) 7.4531(1) 14.9538(2) 12.0617(11)
c (A ˚) 15.1177(2) 9.1995(2) 14.6106(2) 12.3489(2) 14.8889(9)
a ( ) – – – – 113.021(3)
b ( ) – 107.0078(14) 101.8858(5) 117.5968(6) 90.365(3)
c ( ) – – – – 102.513(3)
V (A ˚) 1332.45(3) 2135.72(8) 3790.97(8) 1203.62(3) 1599.4(2)
Z 44 8 4 2
Dcalc. (g cm
–3) 1.755 1.388 1.565 1.724 1.647
l (mm
–1) 2.056 1.296 1.597 2.461 1.580
Absorption correction Multiscan Multiscan Multiscan Multiscan Multiscan
Absorption correction
range
0.71–0.84 0.86–0.96 0.85–0.96 0.74–0.86 0.64–0.87
sin(h/k)max (A ˚ –1) 0.65 0.65 0.60 0.65 0.65
Reﬂections
(measured/unique)
21,618/3,063 11,758/4,644 28,566/3,424 27,341/2,759 35,709/7,342
Parameters/restraints 241/0 251/2 237/0 193/0 438/0
R1/wR2 [I[2r(I)] 0.0182/0.0447 0.0312/0.0694 0.0309/0.0704 0.0306/0.0793 0.0389/0.0867
R1/wR2 (all reﬂections) 0.0190/0.0452 0.0384/0.0723 0.0512/0.0786 0.0389/0.0852 0.0540/0.0947
S 1.062 1.041 1.081 1.089 1.083
Flack parameter [37] –0.006(7) 0.305(9) – – –
Residual density (e A ˚ –3) –0.36/0.19 –0.27/0.41 –0.31/0.43 –0.54/1.23 –0.79/0.51
MIm2Pr 3,3-bis(1-methylimidazol-2-yl)propionate, iPrEtIm2Pr 3,3-bis(1-ethyl-4-isopropylimidazol-2-yl)propionate, and BnMIm2Ac benzyl
bis(1-methylimidazol-2-yl)acetate, MIm2CH2, bis(1-methylimidazol-2-yl)methane
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123using the program EvalCCD [36]. The structure was solved
on the nonoverlapping reﬂections with DIRDIF-99 [34]
using automated Patterson methods. All hydrogen atoms
were located in the difference Fourier map and reﬁned with
a riding model. The twin fraction reﬁned to 0.127(3).
Crystallographic data (without structure factors) for the
structures reported in this paper have been deposited with
the Cambridge Crystallographic Data Centre (CCDC) as
supplementary publication nos. CCDC-637452 for Zn
(MIm2Pr)Cl(H2O)], CCDC-637453 for [Zn(iPrEtIm2Pr)Cl],
CCDC-637454 for ZnCl2(BnMIm2Ac)], CCDC-637455
for [ZnCl2(MIm2CH2)], and CCDC-637456 for [Zn2
(MIm2Pr)2(ox)] 6H2O. Copies of the data can be obtained
free of charge from the CCDC (12 Union Road, Cambridge
CB2 1EZ, UK; Tel.: +44-1223-336408; Fax: +44-1223-
336003; e-mail: deposit@ccdc.cam.ac.uk; Web site http://
www.ccdc.cam.ac.uk).
Results
As part of our efforts to study the coordination chemistry of
the substituted 3,3-bis(1-alkylimidazol-2-yl)propionate
ligand family, the complexes of MIm2Pr and iPrEtIm2Pr
with ZnCl2 were synthesized and structurally characterized
(Fig. 2). MIm2Pr is the parent ligand of the family and
iPrEtIm2Pr offers the most steric hindrance of the ligands
studied so far. The coordination chemistry of MIm2Pr and
iPrEtIm2Pr with zinc was found to be stoichiometry-
dependent.
Zinc complexes of MIm2Pr
The formation of different species upon addition of either
0.5 or 1.0 equiv of ZnCl2 to a solution of the potassium salt
of MIm2Pr in D2O is evidenced by the respective
1HN M R
spectra in D2O (Fig. 3).
All four resonances associated with ligand MIm2Pr
(spectrum a) shifted upon addition of 0.5 equiv of ZnCl2
(spectrum b). The observation of two sharp signals of equal
intensity for the imidazole protons shows that all four
imidazole groups are equivalent. This is indicative of
symmetric binding of both ligands to the zinc ion. The
resonances of the methyl groups and the methine proton at
the bridging carbon shift downﬁeld relative to the free
ligand, whereas the propionate CH2 protons shift upﬁeld.
Note that the methine proton resonance of the free ligand is
hidden under the residual solvent signal in spectrum a. The
lack of any other resonances suggests the clean formation
of a neutral, 2:1 [Zn(MIm2Pr)2] complex. Upon addition of
another 0.5 equiv of ZnCl2 several resonances shift and
signal broadening is observed (spectrum c). Especially, one
of the two imidazole signals is severely broadened. Again,
no free ligand is observed in the spectrum. These obser-
vations indicate a dynamic system with an overall 1:1
ligand–zinc stoichiometry.
The isolation and puriﬁcation of the complex formed
with 2 equiv of MIm2Pr with respect to ZnCl2 proved
troublesome. The separation of the inorganic salts formed
as a by-product in the synthesis by means of repetitive
washing in all cases resulted in partial loss of coordinated
ligand (as observed by NMR), regardless of the A[MIm2Pr]
salt (A is K
+, [Bu4N]
+) originally employed. We therefore
attempted the synthesis of this complex by the reaction of
2 equiv of the acid HMIm2Pr with Zn[N(SiMe3)2]2. Zinc
bis(trimethylsilyl)amide can be synthesized in sizeable
quantities [30] and was found to be a convenient reagent in
this case. Indeed, the reaction of Zn[N(SiMe3)2]2 with
2 equiv of HMIm2Pr in acetonitrile resulted in the forma-
tion of a white precipitate, which was recrystallized from
an acetonitrile–water solution and was identiﬁed as the 2:1
complex [Zn(MIm2Pr)2].
Unfortunately, all attempts at obtaining single crystals
of [Zn(MIm2Pr)2] failed. On the basis of ESI–MS, IR, and
the previously described NMR analysis, we propose that
[Zn(MIm2Pr)2]( F i g .4) is isostructural to the crystallograph-
ically characterized analogous complex [Cu
II(MIm2Pr)2][ 27].
The position of the symmetric and asymmetric carbonyl
stretching vibrations proved to be indicative of the binding
mode of MIm2Pr (Bruijnincx et al., submitted) [27]. The
mas(C=O) and ms(C=O) are found at 1,581 and 1,391 cm
–1,
respectively, indicative of a monodentate binding mode of
the carboxylate [D(mas – ms) = 190 cm
–1, identical to Dionic]
[38]. Furthermore, the clean ESI–MS spectrum of
[Zn(MIm2Pr)2] conﬁrmed the structure of a mononuclear,
neutral 2:1 species with [M + X]
+ (X is H, Na, K) as the
prominent ions.
Fig. 3 400 MHz
1H NMR spectra of the titration of K[MIm2Pr] with
ZnCl2 in D2O at room temperature: a K[MIm2Pr]; b K[MIm2Pr] and
ZnCl2 2:1; c K[MIm2Pr] and ZnCl2 1:1. Asterisks denote the residual
solvent peak
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123The 1:1 complex [Zn(MIm2Pr)Cl)] was synthesized by
the reaction of equimolar amounts of ZnCl2 and K[MIm2Pr]
indrymethanol.Thisledtotheprecipitationandisolationof
[Zn(MIm2Pr)Cl] in almost quantitative yield. The broad-
ened signals in the
1H NMR spectrum of [Zn(MIm2Pr)Cl)]
in D2O prompted us to study this complex by variable-
temperature NMR (Fig. 5). As complex [Zn(MIm2Pr)Cl)] is
insoluble in organic solvents, the variable-temperature
NMR studies were limited to aqueous solutions, which
restricted the temperature range that could be studied.
Spectra were recorded in the range from 2 to 70  C.
Figure 5 shows that at elevated temperatures two sharp
imidazole resonances are observed. In the spectrum rec-
orded at 70  C, the (small) coupling between the two
imidazole protons H1 and H2 can also be discerned. The
imidazole signal at higher ﬁeld broadens upon cooling and
ultimately splits into two separate (broad) resonances. This
implies that at higher temperature the imidazole H1 protons
(Fig. 3) become magnetically equivalent, whereas at lower
temperature exchange slows down with the result that
decoalesence into two broad resonances occurs. This
behavior can be tentatively explained by the possibility of
two different spatial orientations of the imidazole rings
with respect to the carboxylate group of a second ligand
upon coordination to zinc (vide infra), which would result
in nonequivalent imidazole H1 protons at lower tempera-
ture. At higher temperatures these orientations average on
the NMR timescale and only one signal is observed.
The asymmetric and symmetric carbonyl stretch vibra-
tions of isolated [Zn(MIm2Pr)Cl] were observed at 1,615
and 1,390 cm
–1 [D(mas – ms) = 225 cm
–1], respectively. The
asymmetric stretch thus shifted to higher wavenumbers
compared with that observed for [Zn(MIm2Pr)Cl] and a
different, but still monodentate coordination mode of the
carboxylate must therefore be present in [Zn(MIm2Pr)Cl].
The ESI–MS spectrum of [Zn(MIm2Pr)Cl] showed the
presence of several different species, with ions correspond-
ing to, e.g., [MIm2Pr + Zn]
+, [2(MIm2Pr) + Zn + H]
+,
[2(MIm2Pr) + 2Zn + Cl]
+, [3(MIm2Pr) +2Zn + H]
2+ and
[3(MIm2Pr) + 2Zn]
+.OnthebasisoftheNMR,IR,andESI–
MS data, the structure of [Zn(MIm2Pr)Cl] can be described
asanoligomeric/polymericspeciesbothinthesolidstateand
in solution. This was conﬁrmed by the single-crystal struc-
ture determination of [Zn(MIm2Pr)Cl(H2O)].
Crystal structure of [Zn(MIm2Pr)Cl(H2O)]
Colorless single crystals of complex [Zn(MIm2Pr)Cl(H2O)]
suitable for X-ray diffraction were obtained from a solution
of [Zn(MIm2Pr)Cl] in H2O upon standing. The molecular
structureof[Zn(MIm2Pr)Cl(H2O)]isdepictedinFig. 6,with
selected bond lengths and angles presented in Table 2.
The single-crystal structure determination reveals that
the structure of the metal complex is that of a coordination
polymer. The zinc atom is coordinated by two 1-methy-
limidazole groups of one MIm2Pr ligand, while the
carboxylato group of this ligand coordinates to a neighbor-
ing zinc atom. In this way an inﬁnite one-dimensional chain
parallel to the crystallographic c-axis is formed. The
chlorido anion and a coordinated water molecule complete
the coordination sphere around each zinc center and render
it ﬁve-coordinate. Thus, a new, bridging coordination
mode of MIm2Pr is observed in the structure of [Zn
(MIm2Pr)Cl(H2O)] comprising N,N-bidentate coordination
to one metal center and O-monodentate coorrdination to a
second one. This coordination mode complements the
alternative N,N,O-tridentate facial capping mode of the
ligand, which is commonly observed for divalent transition
metals [26, 27, 39]. The coordination geometry around the
Fig. 4 The 2:1 complex [Zn(MIm2Pr)2]
Fig. 5
1H NMR resonances of the imidazole rings of
[Zn(MIm2Pr)Cl] at various temperatures in D2O
Fig. 6 Molecular structure of [Zn(MIm2Pr)Cl(H2O)] in the crystal,
showing three molecules of the carboxylato-bridged coordination
polymer, forming a one-dimensional chain in the crystallographic c-
direction. C–H hydrogen atoms have been omitted for clarity.
Displacement ellipsoids are drawn at the 50% probability level.
Symmetry operation a 3/2 – x,1–y, z – 1/2
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123ﬁve-coordinate Zn atom is distorted trigonal bipyrimidal
(s = 0.72) [40].The equatorialpositions are occupied byN4
and the monoanionic carboxylato O1a and chlorido Cl1
ligands with O1a–Zn1–N4, Cl1–Zn1–O1a, and N4–Zn1–
Cl1 angles of 109.55(5), 130.40(4), and 109.50(4) , res-
pectively (Rangles = 360 ). The axial positions are occupied
byO3ofthewatermoleculeandimidazoleN2[O3–Zn1–N2
173.58(5) ]. The Zn1–N2 and Zn1–N4 bond lengths are
different [2.1203(15) and 2.0517(14) A ˚], consistent with
theirrespectiveaxialandequatorialpositions.TheZn1–O1a
distance of 1.9975(11) A ˚ is slightly longer than the Zn–
Ocarboxylato bond length observed in [Zn(bda
tBu2,Me2)Cl]2
(1.942 A ˚)[ 12] [bpa
tBu2,Me2 is (3,5-di-tert-butylpyrazol-
1-yl)(30,50-dimethylpyrazol-1-yl)acetate], in which a carb-
oxylato group is similarly coordinated to the metal center.
The zinc-aquo distance of 2.1860(13) A ˚ in [Zn(MIm2Pr)
Cl(H2O)] is rather long compared with most reported Zn–
OH2 distances (mean Zn–OH2 distance for ﬁve-coordinate
zinc complexes is 2.046 A ˚; Cambridge Structural Database
version 5.27) [41]. In the related coordination polymer
[Zn(bpa
tBu,Me)(H2O)](ClO4)[ 11] [bpa
tBu,Me is bis(5-tert-
butyl-3-methylpyrazol-2-yl)acetate], where the water mol-
ecule occupies a position in the basal plane of the trigonal
bipyramid,thezinc–waterdistance,forexample,amountsto
1.961 A ˚. [Zn(MIm2Pr)Cl(H2O)] crystallizes in the noncen-
trosymmetric space group P212121 and the determination of
the Flack parameter indicates that the crystal is enantio-
merically pure.
The one-dimensional linear chains in Zn(MIm2Pr)
Cl(H2O)] are interconnected via hydrogen-bonding inter-
actions into a two-dimensional network (Fig. 7, Table 3).
The water molecule binds via its two hydrogen atoms by
hydrogen bonding to a carbonyl O and a chlorido anion as
hydrogen acceptors of a [Zn(MIm2Pr)Cl(H2O)] molecule
in a neighboring strand.
Zinc complexes of iPrEtIm2Pr
In order to assess the inﬂuence of the presence of steric
bulk in the ligand framework, we also studied the zinc
coordination chemistry of ligand iPrEtIm2Pr. The ethyl and
isopropyl substituents of this ligand provide signiﬁcant
steric hindrance and, moreover, increase the solubility of
its complexes in organic solvents. The 1:1 complex
[Zn(iPrEtIm2Pr)Cl] was synthesized by the reaction of
equimolar amounts of ZnCl2 and K[iPrEtIm2Pr] in meth-
anol. The complex was isolated in almost quantitative
yield. The IR spectrum of [Zn(iPrEtIm2Pr)Cl] showed the
asymmetric and symmetric carbonyl stretch vibrations at
1,627 and 1,381 cm
–1 [D(mas – ms) = 246 cm
–1], respec-
tively. The structure of [Zn(iPrEtIm2Pr)Cl] was determined
by X-ray crystal structure determination.
Crystal structure of [Zn(iPrEtIm2Pr)Cl]
Colorless single crystals of [Zn(iPrEtIm2Pr)Cl] suitable for
X-ray diffraction were obtained from a solution of
[Zn(iPrEtIm2Pr)Cl] in methanol. The molecular structure of
[Zn(iPrEtIm2Pr)Cl] is depicted in Fig. 8, with selected bond
lengths and angles presented in Table 4. The crystal struc-
ture shows that whereas like [Zn(MIm2Pr)Cl(H2O)]
[Zn(iPrEtIm2Pr)Cl] also crystallizes as a coordination
polymer, the molecular structure of [Zn(iPrEtIm2Pr)Cl] is
noticeably different. Unlike in the structure of [Zn(MIm2Pr)
Table 2 Selected bond lengths (angstroms) and bond angles (degrees) for [Zn(MIm2Pr)Cl(H2O)]
Bond Bond length Angle Bond angle Angle Bond angle
Zn1–N2 2.1203 (15) N4–Zn1–N2 88.05 (6) N2–Zn1–O1a 92.41 (5)
Zn1–N4 2.0517 (14) N2–Zn1–O3 173.58 (5) O1a–Zn1–O3 82.24 (5)
Zn1–O1a 1.9975 (11) O3–Zn1–N4 90.38 (5) N4–Zn1–Cl1 119.50 (4)
Zn1–Cl1 2.2844 (4) O3–Zn1–Cl1 90.23 (4) Cl1–Zn1–O1a 130.40 (4)
Zn1–O3 2.1860 (13) Cl1–Zn1–N2 95.97 (4) O1a–Zn1–N4 109.55 (5)
Symmetry operation a 3/2 – x,1–y, z – 1/2
Fig. 7 Hydrogen-bonding network in [Zn(MIm2Pr)Cl(H2O)]. Hydro-
gen bonds connect the inﬁnite one-dimensional chains into a two-
dimensional network. C–H hydrogen atoms have been omitted for
clarity. Symmetry operations i 1 – x, 1/2 + y, 1/2 – z; ii –1/2 + x,
3/2 – y,– z
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123Cl(H2O)], no water molecule is found to coordinate to zinc
in [Zn(iPrEtIm2Pr)Cl]. Instead of the ﬁve-coordinate
structure in [Zn(MIm2Pr)Cl(H2O)], the zinc atom in
[Zn(iPrEtIm2Pr)Cl] is four-coordinate. It has a pseudotet-
rahedral coordination geometry with two imidazole groups
of one iPrEtIm2Pr ligand, a chlorido, and a carboxylato
group of a neighboring ligand coordinated to it. The
bridging mode of iPrEtIm2Pr observed in [Zn(iPrEtIm2Pr)
Cl] is the same as found in [Zn(MIm2Pr)Cl(H2O)]. The
deviation from ideal tetrahedral geometry is reﬂected in the
observed bond angles [91.90(9)–119.66(6) ]. The smallest
angle (N2–Zn1–N4) is caused by the inherent geometrical
restrictions imposed by the ligand and the largest angle
(Cl1–Zn1–O1a) probably reﬂects the steric inﬂuence of the
isopropyl groups. The Zn–N, Zn–O, and Zn–Cl bond
lengths in [Zn(iPrEtIm2Pr)Cl] are shorter than the corre-
sponding distancesin [Zn(MIm2Pr)Cl(H2O)], which reﬂects
the stronger Lewis acidity of zinc(II) in a four-coordinate
versus a ﬁve-coordinate geometry. The Zn1–O1a bond
length of 1.9628(19) A ˚ is comparable to values reported for
other tetrahedral N,N,O zinc complexes with a monodentate
carboxylate [9, 11, 12, 18]. The different coordination
geometry at zinc results in a more folded zigzag polymer
chain in [Zn(iPrEtIm2Pr)Cl], compared with the more
stretchedzigzagchainobservedfor[Zn(MIm2Pr)Cl(H2O)].
The structure of [Zn(iPrEtIm2Pr)Cl] and more generally
the coordination chemistry of iPrEtIm2Pr with Zn in
methanol solution were studied by
1H NMR spectroscopy
and ESI–MS. The
1H NMR spectra of a titration experi-
ment comprising the addition of ZnCl2 to the potassium
salt of iPrEtIm2Pr in methanol solution are shown in Fig. 9.
Comparison of the
1H NMR spectra of K[iPrEtIm2Pr]
(Fig. 9, spectrum a) with that of an equimolar K[iPrE-
tIm2Pr]–ZnCl2 mixture shows signiﬁcant shifts pointing to
the formation of a [Zn(iPrEtIm2Pr)Cl] complex (spectrum
b). In the
1H NMR spectrum of [Zn(iPrEtIm2Pr)Cl] one
sharp resonance is observed for the imidazole protons at
6.99 ppm, which is shifted to lower ﬁeld compared with
that of the free ligand. The two imidazole rings are
equivalent on the NMR timescale, suggesting that they are
symmetrically bound to zinc. Importantly, the CH2 reso-
nance of the ethyl groups is shifted and split into two
signals of equal intensity (4.20 and 4.32 ppm). Similarly,
the methyl groups of the isopropyl substituent now appear
as two doublets of equal intensity. These splittings conﬁrm
that the CH2(Et) and CH3(iPr) groupings contain diaste-
reotopic protons and methyl groups, respectively. No
splitting or change in multiplicity of the resonances asso-
ciated with the propionate backbone is observed, which is
indicative of mirror symmetry of the complex in solution.
Although at ﬁrst sight the NMR data would allow an
assignment of the solution structure for [Zn(iPrEtIm2Pr)Cl]
as a mononuclear zinc complex with a facially capped
ligand, a bridged oligomeric species (similar as the one
discussed before for [Zn(MIm2Pr)Cl]) is preferred.
ESI–MS data support the latter description since trimeric,
dimeric, and monomeric species are observed. Prominent
ions corresponding to [Zn(iPrEtIm2Pr)Cl + H]
+, [Zn2
(iPrEtIm2Pr)2Cl2 +H ]
+, and [Zn3(iPrEtIm2Pr)3Cl3 +H ]
+
are, for instance, observed. The structure of [Zn(iPrE-
tIm2Pr)Cl] in solution can therefore best be described as a
coordination polymer similar to [Zn(MIm2Pr)Cl].
Upon addition of 2 equiv of K[iPrEtIm2Pr] to ZnCl2 in
CD3OD (Fig. 9, spectrum c), a second species is formed
next to the 1:1 complex [Zn(iPrEtIm2Pr)Cl]. The fact that
two species are observed, indicates that an equilibrium is
obtained, i.e., the clean formation of a symmetrical 2:1
iPrEtIm2Pr to zinc complex, as previously observed for
MIm2Pr, does not occur. Further inspection of the
1HN M R
spectrum indicated that all resonances of the 1-ethyl-4-
isopropylimidazole groups of the new species are split into
two signals of equal intensity, e.g., the imidazole ring
protons at 7.37 and 7.19 ppm. This suggests that the two
Table 3 Selected hydrogen bond lengths (angstroms) and angles
(degrees) for [Zn(MIm2Pr)Cl(H2O)]
Donor–H   acceptor D–H H   AD    A D–H   A
O3–H1O   O2
i 0.78 (3) 1.95 (3) 2.7307 (19) 176 (3)
O3–H2O   Cl1
ii 0.84 (3) 2.31 (3) 3.1472 (15) 171 (3)
Symmetry operations i 1 – x, 1/2 + y, 1/2 – z; ii –1/2 + x, 3/2 – y,– z
Fig. 8 Molecular structure of [Zn(iPrEtIm2Pr)Cl] in the crystal,
showing three molecules of the carboxylato-bridged coordination
polymer. C–H hydrogen atoms have been omitted for clarity.
Displacement ellipsoids are drawn at the 50% probability level.
Symmetry operation a x,1–y, z – 1/2
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123imidazole groups are inequivalent and experience a dras-
tically different magnetic environment. For instance, the
two resonances of the CH protons of the two isopropyl
groups are found at 2.96 and 1.03 ppm. Furthermore, the
methine proton at the bridging carbon is still a single
triplet, whereas the CH2 group of the propionate backbone
has become diastereotopic. Variable-temperature NMR
studies over a temperature range from –40 to 60  C did not
show signiﬁcant spectral changes. The ESI–MS spectrum
of a 2:1 K[iPrEtIm2Pr]–ZnCl2 solution showed prominent
ions corresponding to the [Zn(iPrEtIm2Pr)2 +H ]
+ and
[Zn(iPrEtIm2Pr)2 + 2H]
2+ cations.
On the basis of these data, the structure of the new
species is proposed to be a 2:1 ligand-to-zinc complex
[Zn(iPrEtIm2Pr)2] in which each ligand is coordinated via
its carboxylate group and one imidazole group, resulting in
a four-coordinated zinc(II) ion (Fig. 10). The coordination
of two of the three donor atoms in a 2:1 ligand-to-metal
complex has also been observed with bulky N,N,S(thiolate)
ligands in the complexes [Zn(L2S)2] [L2SH is (3-tert-
butyl-5-methyl-2-thiophenyl)bis(3,5-dimethyl pyrazolyl)
methane] and [Zn(L
2)2][ L
2 is 1-methoxy-2-methyl-1,1-bis
(1-methyl-4,5-diphenyl-1H-imidazol-2-yl)propane-2-thiol]
[42, 43]. The addition of a third equivalent of K[iPrE-
tIm2Pr] (spectrum d) results in the disappearance of the
signals associated with [Zn(iPrEtIm2Pr)Cl] and both free
ligand K[iPrEtIm2Pr] and [Zn(iPrEtIm2Pr)2] are detected.
No attempts to isolate [Zn(iPrEtIm2Pr)2] were undertaken.
Attempted synthesis of a zinc bis(1-methylimidazol-2-yl)
acetate complex
Recently, the zinc coordination chemistry of bis(pyrazolyl)
acetates (bpa) has been actively explored to mimic the
2-His-1-carboxylate facial triad found in several different
zinc enzymes [9, 11, 12, 18, 19]. The backbone of bpa is
more rigid than the backbone of the ligands MIm2Pr and
iPrEtIm2Pr used in the present study. In particular, the
bridging N,N-bidentate-O-monodentate coordination mode
reported here is less favorable for bpa, for which a strong
predisposition to an N,N,O facial capping mode is expec-
ted. The synthesis of zinc complexes of MIm2Ac would
therefore be desirable, since it would allow a direct com-
parison of the respective pyrazole and imidazole donor
groups (Fig. 11).
We attempted the synthesis of ligand MIm2Ac, but found
that the common synthetic procedure, i.e., lithiation of
MIm2CH2 followed by reaction with carbon dioxide [45],
did not result in product formation in acceptable yields.
Table 4 Selected bond lengths (angstroms) and bond angles (degrees) for [Zn(iPrEtIm2Pr)Cl]
Bond Bond length Angle Bond angle Angle Bond angle
Zn1–N2 2.038 (2) Cl1–Zn1–N2 116.85 (7) N2–Zn1–O1a 108.85 (8)
Zn1–N4 2.045 (2) Cl1–Zn1–N4 112.12 (7) N4–Zn1–O1a 103.15 (9)
Zn1–O1a 1.9628 (19) Cl1–Zn1–O1a 119.66 (6)
Zn1–Cl1 2.2146 (7) N2–Zn1–N4 91.90 (9)
Symmetry operation a x,1–y, z – 1/2
Fig. 9 400 MHz
1H NMR
spectra of the titration of
K[iPrEtIm2Pr] with ZnCl2 in
CD3OD at room temperature: a
K[iPrEtIm2Pr] and ZnCl2 1:0; b
K[iPrEtIm2Pr] and ZnCl2 1:1; c
K[iPrEtIm2Pr] and ZnCl2 2:1; d
K[iPrEtIm2Pr] and ZnCl2 3:1.
Asterisks denote the residual
solvent peak and H2O
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123Instead, it was found that the ligand or an ester precursor of
the ligand decarboxylates rather easily, as was also
observed by Peters et al. [39]. The benzyl ester of bis(1-
methylimidazol-2-yl)acetic acid (BnMIm2Ac), however,
was sufﬁciently stable and could be isolated and puriﬁed
after reaction of lithio bis(1-methylimidazol-2-yl)methane
with benzylchloroformate. Since hydrolysis and hydrogen-
olysis of the ester moiety resulted in decomposition of the
ligand, the 1:1 zinc dichloride complex with BnMIm2Ac
was synthesized in the hope that autocatalytic ester hydro-
lysis by the zinc complex would yield the desired zinc bis
(1-methylimidazol-2-yl)acetate complex. A similar app-
roach, involving the autocatalytic saponiﬁcation of a zinc
bis(picolyl)glycine ethyl ester complex, has been reported
by Abufarag and Vahrenkamp [46].
The reaction of equimolar amounts of ZnCl2 and
BnMIm2Ac gave the complex [ZnCl2(BnMIm2Ac)] as a
white powder in quantitative yield. The structure of
[ZnCl2(BnMIm2Ac)] was determined by X-ray diffraction
studies and showed the BnMIm2Ac ligand bound to the
zinc center in an N,N-bidentate way (Fig. 12, top). How-
ever, stirring of [ZnCl2(BnMIm2Ac)] in H2O at room
temperature in an attempt to obtain [Zn(MIm2Ac)Cl]
resulted in decomposition of the ligand and formation of
[ZnCl2(MIm2CH2)], which was isolated as one of the
decomposition products. [ZnCl2(MIm2CH2)] was also
characterized crystallographically (Fig. 12, bottom). On
the basis of these ﬁndings, it was concluded that the
MIm2Ac monoanion is too unstable for practical studies
and the pursuit of this ligand was abandoned.
Reaction of [Zn(MIm2Pr)Cl] with sodium pyruvate:
oxalate formation
In an attempt to prevent the formation of coordination poly-
mers of MIm2Pr and to obtain mononuclear complexes with
the desired N,N,O facial capping mode of the ligand, several
different monoanionic, bidendate coligands were used. In the
course of this study, we also investigated the reaction of
[Zn(MIm2Pr)Cl] with sodium pyruvate. The addition of
1 equiv of sodium pyruvate to a solution of [Zn(MIm2Pr)Cl]
in D2O resulted in the appearance of a new singlet at
2.38 ppm in the
1H NMR spectrum (Fig. 13, top spectrum).
Thesignalisnotshiftedwithrespecttothesignalobservedfor
free sodium pyruvate, which indicates that the interaction
between [Zn(MIm2Pr)Cl] and the pyruvate anion is weak, at
best. The ESI–MS spectrum of an aqueous solution of equi-
molar amounts of [Zn(MIm2Pr)Cl] and sodium pyruvate,
however, did show some major ions corresponding to a
mononuclear {[Zn(MIm2Pr)(pyruvate)] + Na}
+ and a dinu-
clear {[Zn2(MIm2Pr)2(pyruvate)]}
+ cation, in addition to the
ions observed in the ESI–MS spectrum of a solution of
[Zn(MIm2Pr)Cl] in water.
However, when the mixture of [Zn(MIm2Pr)Cl] and
pyruvate in D2O was followed in time by NMR spectros-
copy, the gradual decrease in intensity of the signal of the
pyruvate methyl group was noticed until it ultimately dis-
appeared (Fig. 13, bottom spectrum). After several days
colorless crystals suitable for X-ray diffraction studies were
formed in the NMR tube. To our surprise, the X-ray crystal
structure showed the structure of the zinc complex
[Zn2(MIm2Pr)2(ox)] 6H2O. [Zn2(MIm2Pr)2(ox)] 6H2O has
the structure of a coordination polymer involving
[Zn(MIm2Pr)]
+ cations bridged by oxalato dianions.
Fig. 10 Proposed structure for [Zn(iPrEtIm2Pr)2]. The structure was
calculated by molecular mechanics geometry optimization (Spartan
SGI [44] MMFF94)
Fig. 11 Ligands benzyl bis
(1-methylimidazol-2-yl)acetate
(BnMIm2Ac), MIm2Ac, and
bis(pyrazolyl)acetate (bpa) and
the synthesis of complexes
[ZnCl2(BnMIm2Ac)] and
[ZnCl2(MIm2CH2)]
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123To unequivocally prove the relevance of the structure
obtained, zinc coordination polymer [Zn2(MIm2Pr)2(ox)]
was also synthesized independently. Indeed, the addition of
0.5 equiv of K2C2O4 H2O to an aqueous solution of
[Zn(MIm2Pr)Cl] yielded a white, insoluble powder. This
powder was identiﬁed as [Zn2(MIm2Pr)2(ox)] by elemental
analysis and IR spectroscopy. Typical features of the IR
spectrum of [Zn2(MIm2Pr)2(ox)] include absorptions at
1,674, 1,638, 1,591, and 1,399 cm
–1, which can be
attributed to the oxalato and carboxylato groups in the
polymer. Crystallization of [Zn2(MIm2Pr)2(ox)] proved
difﬁcult given its general insolubility. Single crystals
could, however, be obtained via the gel crystallization
method [47]. A gel formed from a solution of tetrameth-
oxysilane and potassium oxalate hydrate in water was
layered with an aqueous solution of K[MIm2Pr] and ZnCl2.
Single crystals were obtained after several days and could
be unequivocally identiﬁed as [Zn2(MIm2Pr)2(ox)] by
X-ray crystal structure determination.
Crystal structure of [Zn2(MIm2Pr)2(ox)] 6H2O
The molecular structure of [Zn2(MIm2Pr)2(ox)] 6H2Oi s
shown in Fig. 14, with selected bond lengths and angles
presented in Table 5.
1 The polymeric structure of
[Zn2(MIm2Pr)2(ox)] 6H2O comprises two crystallographi-
cally inequivalent zinc atoms. Both zinc centers are ﬁve-
coordinate and differ only in the slightly different bond
lengths and angles. Each zinc atom is coordinated in an
N,N-bidentate fashion by the 1-methylimidazole groups of
one MIm2Pr ligand, two oxygen atoms of a bis O,O-bid-
entate bridging oxalato group, and a carboxylato O donor
atom of a neighboring MIm2Pr ligand. The combination of
the bridging oxalato and MIm2Pr ligands constructs a
polymeric structure leading to the formation of two-
dimensional sheets.
The coordination geometry around each zinc center is
best described as a severely distorted trigonal bipyramid,
with s values of 0.60 and 0.59 for Zn1 and Zn2, respec-
tively [40]. The equatorial positions are occupied by N24b/
N14, and the anionic carboxylato O11/O21 and oxalato
O32/O42 ligands for Zn1/Zn2, respectively. The axial
positions are occupied by O31/O41 of the oxalato group
and imidazole N22b/N12 for Zn1/Zn2 [O–Zn–N angles of
161.43(9) /160.51(8) ]. The planar oxalato moieties are
rather asymmetrically bound to the metal centers, with the
Zn1–O31 and Zn1–O32 distances amounting to 2.258(2)
and 2.018(2) A ˚, for instance. This asymmetry has also been
observed in other bisbidentate bridged zinc–oxalato com-
plexes with ﬁve-coordinated metal centers and is consistent
with the occupation of one equatorial and one axial site of
the trigonal bipyramid [10, 48]. The shortest Zn   Zn dis-
tances via the bridging oxalato group are 5.5667(7) A ˚ for
Zn1   Zn1d and 5.5332(7) A ˚ for Zn2   Zn2c. The distances
of the metal centers to the donor atoms of MIm2Pr follow
the same trend as observed in [Zn(MIm2Pr)Cl(H2O)]. The
crystal structure of [Zn2(MIm2Pr)2(ox)] 6H2O is further
Fig. 12 Molecular structures of [ZnCl2(BnMIm2Ac)] (top) and
[ZnCl2(MIm2CH2)] (bottom) in the crystal. Displacement ellipsoids
are drawn at the 50% probability level. All hydrogen atoms have been
omitted for clarity. Selected bond lengths (angstroms) as follows:
[ZnCl2(BnMIm2Ac)], Zn1–N2 2.011(2), Zn1–N4 1.994(2), Zn1–Cl1
2.2242(7), Zn1–Cl2 2.2554(7); [ZnCl2(MIm2CH2)], Zn1–N2
2.0247(17), Zn1–N4 2.0222(17), Zn1–Cl1 2.2110(6), Zn1–Cl2
2.2504(6)
Fig. 13
1H NMR spectra of a solution of [Zn(MIm2Pr)Cl] in D2O
(asterisk) after addition of 1 equiv of sodium pyruvate and the same
solution after 24 h
1 The possibility of the presence of an enolate dianion in the crystal
structure of [Zn2(MIm2Pr)2(ox)] 6H2O could be unequivocally ruled
out on the basis of crystallographic arguments.
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123stabilized by 14 different hydrogen-bonding interactions,
which involve the cocrystallized water molecules, the ox-
alato bridges, and the carboxylato groups (Fig. 15). The
oxalato groups are, for instance, involved in two chelated,
three-centered hydrogen bonds with two water molecules
via four O–H   O hydrogen bonds.
Discussion
The aim of this investigation was to explore the biomimetic
modeling potential of the MIm2Pr ligand family with
respect to mononuclear zinc enzymes featuring the 2-His-
1-carboxylate facial triad. Complex [Zn(MImPr)2] shows
that the facial capping mode of MIm2Pr, as earlier observed
with copper [27, 28] and iron (Bruijnincx et al., submitted)
[26], is also accessible for zinc. The crystal structure of the
1:1 complex [Zn(MIm2Pr)Cl(H2O)], however, shows that
MIm2Pr can also adopt other coordination modes. The
formation of the oligomeric/polymeric structure of
[Zn(MIm2Pr)Cl], both in solution and in the solid state, can
be attributed to the ﬂexibility of the ligand due to the CH2
spacer of the propionate backbone. The formation of
polymeric [Zn(MIm2Pr)Cl(H2O)] is further aided by the
insolubility of the resulting coordination polymer. Two
strategies were explored to circumvent polymer formation,
i.e., increasing the steric bulk of the ligand and elimination
of the CH2 spacer. The latter approach demanded the
synthesis of the bis(1-methylimidazol-2-yl)acetate ana-
logue of MIm2Pr, which was found to be rather unstable
and its zinc complexes could not be obtained. The effect of
more steric bulk was studied with iPrEtIm2Pr, which con-
tains the sterically more demanding isopropyl and ethyl
substituents. Zinc complexes of iPrEtIm2Pr are polymeric
in nature as well, albeit with a different coordination
geometry at the zinc atom as observed in [Zn(MIm2Pr)
Cl(H2O)]. The ﬁrst coordination spheres of [Zn(MIm2Pr)
Cl(H2O)] and [Zn(iPrEtIm2Pr)Cl] are compared in Fig. 16.
Fig. 14 Molecular structure of
[Zn2(MIm2Pr)2(ox)] 6H2Oi n
the crystal. C–H hydrogen
atoms and all solvent water
molecules have been omitted for
clarity. Displacement ellipsoids
are drawn at the 50%
probability level
Table 5 Selected bond lengths
(angstroms) and angles
(degrees) for
[Zn2(MIm2Pr)2(ox)] 6H2O
Symmetry operations b 1 + x, y,
z;c– x,1–y,– z;d1–x,1–y,
1–z
Bond Bond length Angle Bond angle Angle Bond angle
Zn1–O31 2.258 (2) O11–Zn1–O31 89.48 (8) O21–Zn2–O41 90.33 (8)
Zn1–O32 2.018 (2) O11–Zn1–O32 124.09 (9) O21–Zn2–O42 125.19 (8)
Zn1–O11 1.9694 (19) O11–Zn1–N22b 108.91 (9) O21–Zn2–N12 109.08 (9)
Zn1–N24b 2.046 (2) O11–Zn1–N24b 107.61 (9) O21–Zn2–N14 107.85 (9)
Zn1–N22b 2.088 (2) O31–Zn1–O32 77.16 (9) O41–Zn2–O42 77.84 (8)
Zn2–O41 2.233 (2) O31–Zn1–N22b 161.43 (9) O41–Zn2–N12 160.51 (8)
Zn2–O42 2.0179 (19) O31–Zn1–N24b 87.69 (9) O41–Zn2–N14 87.24 (9)
Zn2–O21 1.9630 (19) O32–Zn1–N22b 89.94 (8) O42–Zn2–N12 89.12 (8)
Zn2–N12 2.089 (2) O32–Zn1–N24b 125.38 (9) O42–Zn2–N14 124.42 (9)
Zn2–N14 2.052 (2) N22b–Zn1–N24b 89.06 (9) N12–Zn2–N14 88.34 (9)
C31–O31 1.248 (4) C41–O41 1.250 (3)
C31d–O32 1.252 (4) C41c–O42 1.254 (3)
C31–C31d 1.544 (6) C41–C41c 1.537 (6)
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123The added steric bulk in iPrEtIm2Pr causes the zinc ion to
adopt a pseudotetrahedral geometry in [Zn(iPrEtIm2Pr)Cl],
instead of the distorted trigonal bipyramid observed for
[Zn(MIm2Pr)Cl(H2O)]. The coordination around zinc in
[Zn(iPrEtIm2Pr)Cl] resembles the ﬁrst coordination sphere
of the active sites of the zinc enzymes thermolysin, car-
boxypeptidase A, and neutral protease. The polymeric
rather than monomeric nature of the complex, however,
clearly limits its potential as a biological mimic.
The isolation of [Zn2(MIm2Pr)2(ox)] from the reaction
of [Zn(MIm2Pr)Cl] with sodium pyruvate was rather
unexpected and is, to the best of our knowledge, the ﬁrst
report of the nonoxidative formation of oxalate from
pyruvate (Scheme 1).
2 Interestingly, Takeste and Vah-
renkamp [51] very recently reported a trispyrazolylborato–
zinc complex with pyruvate, representing the ﬁrst struc-
turally characterized zinc complex of an a-keto acid.
Although in their case the zinc–pyruvate complex obtained
was stable, unexpected cleavage reactions with other
a-keto acids, such as benzoylformic acid, and a-diketones
were observed.
A control experiment showed that an aqueous sodium
pyruvate solution is stable under the reaction conditions.
Apparently, [Zn(MIm2Pr)Cl] mediates the conversion of
pyruvate to oxalate. The product [Zn2(MIm2Pr)2(ox)]
invariably deposited as crystals in experiments done on the
NMR scale. On a preparative scale (0.3 mmol), the reaction
also takes place, yet the product was isolated as an insoluble
white powder. The IR spectrum of this powder was identi-
cal to that obtained for independently synthesized [Zn2
(MIm2Pr)2(ox)]. Most importantly, further experiments
revealed that the reaction is catalytic in zinc. For example,
addition of 20 equiv of sodium pyruvate to a solution of
[Zn(MIm2Pr)Cl] in water under ambient conditions resulted
in ten turnovers after 24 h. The disappearance of the pyru-
vatemethylsignalwasalsoobservedinasolutioncontaining
ZnCl2 and sodium pyruvate without any further additives.
Concomitantly,aprecipitatewasobservedintheNMRtube.
However, the composition of this precipitate, i.e., the for-
mation of oxalate, could not be unambiguously established.
Fig. 15 Hydrogen bonding network and crystal packing of
[Zn2(MIm2Pr)2(ox)] 6H2O
Fig. 16 Comparison of the ﬁrst coordination spheres of the zinc
atoms in the coordination polymers [Zn(MIm2Pr)Cl(H2O)] (top) and
[Zn(iPrEtIm2Pr)Cl] (bottom)
Scheme 1 The observed transformation of pyruvate to oxalate
mediated by [Zn(MIm2Pr)Cl]
2 Unexpected oxalate formation by Zn complexes is not completely
unprecedented. The reaction of Zn(NO3)2 with pyridine-2,4,6-tricar-
boxylic acid in the presence of pyridine at room temperature resulted,
for instance, in the formation of the zinc oxalato polymer
[Zn(ox)(py)2] H2O[ 49]. Another oxalato bridged zinc coordination
polymer was obtained from the hydro(solvo)thermal reaction between
Zn(NO3)2 and pyridine in ethanol or methanol [50]. It was proposed
that the oxalate resulted from ethanol oxidation and oxidative
coupling of methanol for the two different solvents, respectively.
Clearly, different reaction mechanisms are operative in these cases.
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123Since it is known that pyruvate keto–enol tautomeriza-
tion is catalyzed by divalent metal ions such as Zn(II) [52,
53], the disappearance of the methyl signal could in prin-
ciple also be attributed to consecutive H/D-exchange steps.
This would yield the deuterated pyruvate-d3 anion, which
is also invisible in
1H NMR spectroscopy. To be able to
exclude this possibility, experiments were performed in
H2O and samples were diluted with 2 equiv of D2O just
before the measurement. The same observations were made
as previously, i.e., gradual disappearance of the methyl
signal and slow crystallization of the product in the NMR
tube. The presence of appreciable amounts of enolate
should also lead to the detection of the dimerization
product of pyruvate [52, 53]. This pyruvate dimer, which
results from an aldol condensation reaction and has
characteristic signals at 1.38 (singlet) and 3.35 (AB pat-
tern) ppm [52–54], was not observed under these
conditions.
Phenyl pyruvic acid (and other a-ketoacids) is oxidized
by molecular oxygen to give benzaldehyde and oxalate or
the carbon oxides (CO and/or CO2)[ 55, 56]. This reaction
is catalyzed by several metal ions, such as Mn(II), Fe(II),
and Cu(II), but not by Zn(II) [57, 58], and has been
attributed to the presence of the enol tautomer, which is
capable of reacting with dioxygen [61]. In the absence of
dioxygen, i.e., under an Ar atmosphere, pyruvate does react
with [Zn(MIm2Pr)Cl] to form oxalate. The anaerobic
reactivity cannot be attributed to any residual dioxygen
traces, since phenyl pyruvate (a substrate more prone to the
reaction with dioxygen) did not show any reactivity under
these conditions.
The observed conversion of pyruvate to oxalate under
anaerobic conditions clearly places it outside previously
observed formation of oxalate from oxidative transforma-
tions of a-keto acids [55, 56, 59–63]. The observation is
important, since pyruvate is a major metabolic junction and
it is therefore of prime importance to understand its reac-
tivity. At present no biological counterpart has been
reported for the pyruvate–oxalate conversion catalyzed by
[Zn(MIm2Pr)Cl]. The chemical transformation as reported
here, however, takes place at room temperature and phys-
iological pH and should therefore be considered as a
possible alternative pathway in the reactivity of pyruvate.
The mechanism of this conversion is currently not clear.
No other products could be detected by NMR during the
reaction, which precludes the formulation of a mass bal-
ance for the reaction and clearly hampers a mechanistic
interpretation. In any case, the pyruvate to oxalate con-
version requires the scission of a C–C bond. On the other
hand, the reactivity of zinc enzymes and their model
complexes is often of hydrolytic nature. This can be
attributed to the generation of a nucleophilic hydroxide
species and/or the activation of a coordinated substrate
towards attack of such a nucleophile [3]. The formation of
oxalate from pyruvate via a hydrolytic mechanism is,
however, difﬁcult to envision. Further investigations have
to be performed to address the mechanistic questions
concerning this transformation.
Conclusions
The difference in applied steric bulk by the ligands MIm2Pr
and iPrEtIm2Pr is reﬂected in the coordination chemistry of
the two ligands towards ZnCl2. Octahedral (MIm2Pr) ver-
sus tetrahedral (iPrEtIm2Pr) and trigonal pyramidal
(MIm2Pr) versus tetrahedral (iPrEtIm2Pr) coordination
geometries were obtained in the 1:1 and 2:1 ligand-to-
metal complexes, respectively. The bridging binding mode
of the two crystallographically characterized coordination
polymers illustrates the intrinsic ﬂexibility of the 3,3-
bis(imidazol-2-yl)propionate ligand framework. The poly-
meric nature of the complexes could limit their biological
relevance with respect to the 2-His-1-carboxylate facial
triad in the case of zinc. On the other hand, attempts aimed
at obtaining structurally more faithful mononuclear com-
plexes led to the observation of the unprecedented
Zn-mediated pyruvate to oxalate conversion. This new,
nonoxidative transformation of an important metabolic
junction is intriguing and warrants further investigation.
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